AbbVie Inc. (ABBV) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AbbVie Inc. (ABBV) CIK: 0001551152 --- Reporting Owner --- Name: RAPP EDWARD J CIK: 0001171780 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock, $0.01 par value Date: 2026-05-08 | Code: A (Grant or award) Shares: +1,118 | Price: $0.00 Shares Owned After: 45,964 | Ownership: D (Direct) Footnotes: [F1] These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). [F2] Total holdings include 10,388 shares in trust previously held indirectly by spouse, now held directly. --- Footnotes (Complete Index) --- F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F2: Total holdings include 10,388 shares in trust previously held indirectly by spouse, now held directly. --- Signature --- /s/ /s/ T.O. Odutayo, attorney-in-fact for Edward J. Rapp (2026-05-12)